CSP
PGEN icon

Cary Street Partners’s Precigen PGEN Stock Holding History

Cary Street Partners’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Hold
87,593
– – 0.01% 664
2026
Q1 		$339K Hold
87,593
– – 0.01% 686
2025
Q4 		$366K Hold
87,593
– – 0.01% 677
2025
Q3 		$288K Hold
87,593
– – 0.01% 694
2025
Q2 		$124K Hold
87,593
– – ﹤0.01% 828
2025
Q1 		$131K Hold
87,593
– – ﹤0.01% 789
2024
Q4 		$98.1K Buy
+87,593
New +$74.7K ﹤0.01% 783

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cary Street Partners's PGEN Position: Q2 2026 in Review

Cary Street Partners held its Precigen (PGEN) position steady in Q2 2026 at 87,593 shares worth $499K. The position accounts for 0.01% of the portfolio, ranked #664.

Cary Street Partners first reported a position in PGEN in Q4 2024 and has held it in 7 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Cary Street Partners held 87,593 shares of Precigen worth $499K as of Q2 2026.
  • Cary Street Partners left its Precigen share count unchanged in Q2 2026.
  • Precigen made up 0.01% of Cary Street Partners's portfolio in Q2 2026, its #664 holding.
  • Cary Street Partners first reported a position in Precigen in Q4 2024 and has held it in 7 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.